Isolation and characterisation of new putative probiotic bacteria from human colonic flora

British Journal of Nutrition

Volumn 97, Issue 4, 2007, Pages 725-734

  Raz, Irit ^a   Gollop, Natan ^b   Polak Charcon, Sylvie ^c   Schwartz, Betty ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b VOLCANI CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Butyrate; Butyrate kinase; Enterococcus durans; Intestinal microflora; Probiotics; Short chain fatty acids

Indexed keywords

BILE ACID; BUTYRIC ACID; COMPLEMENTARY DNA; DEXTRAN; INTERLEUKIN 1BETA; PHOSPHOTRANSFERASE; PROBIOTIC AGENT; RNA 16S; SODIUM SULFATE; TUMOR NECROSIS FACTOR ALPHA;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL SURVIVAL; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOCHEMISTRY; CELL STRAIN CACO 2; CLOSTRIDIUM; COLON FLORA; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENTEROCOCCUS; ENTEROCOCCUS DURANS; FECES; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS DELBRUECKII; MALE; MOUSE; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; SCORING SYSTEM; ULCERATIVE COLITIS;

BACTERIAL ADHESION; BUTYRATES; CACO-2 CELLS; COLITIS; COLON; COLONY COUNT, MICROBIAL; DEXTRAN SULFATE; ENTEROCOCCUS; FECES; HUMANS; HYDROGEN-ION CONCENTRATION; IN SITU HYBRIDIZATION, FLUORESCENCE; PROBIOTICS;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM; ENTEROCOCCUS DURANS; LACTOBACILLUS DELBRUECKII; MUS;

EID: 33947505331     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711450747249X     Document Type: Article

References (39)

1. Ahmad MS, Krishnan S, Ramakrishna BS, Mathan M, Pulimood AB & Murthy SN (2000) Butyrate and glucose metabolism by colonocytes in experimental colitis in mice. Gut 46, 493-499.
2. Avivi-Green C, Madar Z & Schwartz B (2000) Pectin-enriched diet affects distribution and expression of apoptosis-cascade proteins in colonic crypts of dimethylhydrazine-treated rats. Int J Mol Med 6, 689-698.
3. Avivi-Green C, Polak-Charcon S, Madar Z & Schwartz B (2002) Different molecular events account for butyrate-induced apoptosis in two human colon cancer cell lines. J Nutr 132, 1812-1818.
4. Barcenilla A, Pryde SE, Martin JC, Duncan SH, Stewart CS, Henderson C & Flint HJ (2000) Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol 66, 1654-1661.
5. Chen CC & Walker WA (2005) Probiotics and prebiotics: Role in clinical disease states. Adv Pediatr 52, 77-113.
6. Collado MC, Hernandez M & Sanz Y (2005) Production of bacteriocin-like inhibitory compounds by human fecal Bifidobacterium strains. J Food Prot 68, 1034-1040.
7. Cooper HS, Murthy SN, Shah RS & Sedergran DJ (1993) Clinico-pathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69, 238-249.
8. D'Argenio G & Mazzacca G (1999) Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer. Adv Exp Med Biol 472, 149-158.
9. Diakos C, Prieschl EE, Saemann M, Novotny V, Bohmig G, Csonga R, Baumruker T & Zlabinger GJ (2002) Novel mode of interference with nuclear factor of activated T-cells regulation in T-cells by the bacterial metabolite n-butyrate. J Biol Chem 277, 24243-24251.
10. Djouzi Z, Andrieux C, Degivry MC, Bouley C & Szylit O (1997) The association of yogurt starters with Lactobacillus casei DN 114.001 in fermented milk alters the composition and metabolism of intestinal microflora in germ-free rats and in human flora-associated rats. J Nutr 127, 2260-2266.
11. Duncan SH, Barcenilla A, Stewart CS, Pryde SE & Flint HJ (2002) Acetate utilization and butyryl coenzyme A (CoA): acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol 68, 5186-5190.
12. Duncan SH, Holtrop G, Lobley GE, Calder AG, Stewart CS & Flint HJ (2004a) Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr 91, 915-923.
13. Duncan SH, Louis P & Flint HJ (2004b) Lactate-utilizing bacteria, isolated from human faeces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 70, 5810-5817.
14. Duncan SH, Scott KP, Ramsay AG, Harmsen HJ, Welling GW, Stewart CS & Flint HJ (2003) Effects of alternative dietary substrates on competition between human colonic bacteria in an anaerobic fermentor system. Appl Environ Microbiol 69, 1136-1142.
15. Edelman MJ, Bauer K, Khanwani S, Tait N, Trepel J, Karp J, Nemieboka N, Chung EJ & Van Echo D (2003) Clinical and pharmacologic study of tributyrin: An oral butyrate prodrug. Cancer Chemother Pharmacol 51, 439-444.
16. Erickson KL & Hubbard NE (2000) Probiotic immunomodulation in health and disease. J Nutr 130, 403S-409S.
17. Frankel WL, Zhang W, Singh A, Klurfeld DM, Don S, Sakata T, Modlin I & Rombeau JL (1994) Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon. Gastroenterology 106, 375-380.
18. Franz CM, Holzapfel WH & Stiles ME (1999) Enterococci at the crossroads of food safety? Int J Food Microbiol 47, 1-24.
19. Galvez J, Rodriguez-Cabezas ME & Zarzuelo A (2005) Effects of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res 49, 601-608.
20. Hallert C, Bjorck I, Nyman M, Pousette A, Granno C & Svensson H (2003) Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis 9, 116-121.
21. Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, Moller PL, Michaelsen KF, Paerregaard A, Sandstrom B, Tvede M & Jakobsen M (1999) Screening of probiotic activities of fortyseven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 65, 4949-4956.
22. Kalliomaki MA & Isolauri E (2004) Probiotics and down-regulation of the allergic response. Immunol Allergy Clin North Am 24, 739-752, viii.
23. Kawalec M, Potempa J, Moon JL, Travis J & Murray BE (2005) Molecular diversity of a putative virulence factor: Purification and characterization of isoforms of an extracellular serine glutamyl endopeptidase of Enterococcus faecalis with different enzymatic activities. J Bacteriol 187, 266-275.
24. Klein G (2003) Taxonomy, ecology and antibiotic resistance of enterococci from food and the gastro-intestinal tract. Int J Food Microbiol 88, 123-131.
25. Louis P, Duncan SH, McCrae SI, Millar J, Jackson MS & Flint HJ (2004) Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J Bacteriol 186, 2099-2106.
26. Luhrs H, Gerke T, Boxberger F, Backhaus K, Melcher R, Scheppach W & Menzel T (2001) Butyrate inhibits interleukin-1-mediated nuclear factor-kappa B activation in human epithelial cells. Dig Dis Sci 46, 1968-1973.
27. Luhrs H, Gerke T, Muller JG, Melcher R, Schauber J, Boxberge F, Scheppach W & Menzel T (2002) Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 37, 458-466.
28. O'Sullivan GC, Kelly P, O'Halloran S, Collins C, Collins JK, Dunne C & Shanahan F (2005) Probiotics: An emerging therapy. Curr Pharm Des 11, 3-10.
29. Otles S, Cagindi O & Akcicek E (2003) Probiotics and health. Asian Pac J Cancer Prev 4, 369-372.
30. Pereira DI & Gibson GR (2002) Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol 68, 4689-4693.
31. Resta-Lenert S & Barrett KE (2003) Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52, 988-997.
32. Saggioro A (2004) Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 38, S104-S106.
33. Schultz M, Strauch UG, Linde HJ, Watzl S, Obermeier F, Gottl C, Dunger N, Grunwald N, Scholmerich J & Rath HC (2004) Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin Diagn Lab Immunol 11, 372-378.
34. Snelling AM (2005) Effects of probiotics on the gastrointestinal tract. Curr Opin Infect Dis 18, 420-426.
35. Tuomola EM & Salminen SJ (1998) Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol 41, 45-51.
36. Vernia P, Annese V, Bresci G, et al. (2003) Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: Results of a multicentre trial. Eur J Clin Invest 33, 244-248.
37. Vine DF, Charman SA, Gibson PR, Sinclair AJ & Porter CJ (2002) Effect of dietary fatty acids on the intestinal permeability of marker drug compounds in excised rat jejunum. J Pharm Pharmacol 54, 809-819.
38. Walker AW, Duncan SH, McWilliam Leitch EC, Child MW & Flint HJ (2005 pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol 71, 3692-3700.
39. Wilson M, Hall V, Brazier J & Lewis MA (2000) Evaluation of a phenotypic scheme for identification of the 'butyrate-producing' Peptostreptococcus species. J Med Microbiol 49, 747-751.